150 related articles for article (PubMed ID: 38189395)
1. [Lithocholic acid decreases mRNA stability of nuclear receptor PPAR
Pang B; Huang N; Huang X; Li X; Xiong W; Kong B; Yao Y
Nan Fang Yi Ke Da Xue Xue Bao; 2023 Dec; 43(12):2086-2094. PubMed ID: 38189395
[TBL] [Abstract][Full Text] [Related]
2. PPARα is regulated by miR-21 and miR-27b in human liver.
Kida K; Nakajima M; Mohri T; Oda Y; Takagi S; Fukami T; Yokoi T
Pharm Res; 2011 Oct; 28(10):2467-76. PubMed ID: 21562928
[TBL] [Abstract][Full Text] [Related]
3. MiR-506 suppresses proliferation of hepatoma cells through targeting YAP mRNA 3'UTR.
Wang Y; Cui M; Sun BD; Liu FB; Zhang XD; Ye LH
Acta Pharmacol Sin; 2014 Sep; 35(9):1207-14. PubMed ID: 25087998
[TBL] [Abstract][Full Text] [Related]
4. [The effects of microRNA-7 on proliferation and invasion of hepatocellular carcinoma HepG2 cells].
Qin AD; Liu XX; Li J; Liu J; Li YS
Zhonghua Zhong Liu Za Zhi; 2018 Jun; 40(6):406-411. PubMed ID: 29936764
[No Abstract] [Full Text] [Related]
5. Suppression of Hepatic PPARα in Primary Biliary Cholangitis Is Modulated by miR-155.
Adamowicz M; Kempinska-Podhorodecka A; Abramczyk J; Banales JM; Milkiewicz P; Milkiewicz M
Cells; 2022 Sep; 11(18):. PubMed ID: 36139455
[TBL] [Abstract][Full Text] [Related]
6. [Construction of human Bcl-6 3'UTR reporter vector and expression vector and their functional assessment].
Han BY; Cui HZ; Yan X; Huang P; Huang HL; Fan ZY; Dou JT
Nan Fang Yi Ke Da Xue Xue Bao; 2015 Oct; 35(10):1451-6. PubMed ID: 26547340
[TBL] [Abstract][Full Text] [Related]
7. Functional microRNA high throughput screening reveals miR-9 as a central regulator of liver oncogenesis by affecting the PPARA-CDH1 pathway.
Drakaki A; Hatziapostolou M; Polytarchou C; Vorvis C; Poultsides GA; Souglakos J; Georgoulias V; Iliopoulos D
BMC Cancer; 2015 Jul; 15():542. PubMed ID: 26206264
[TBL] [Abstract][Full Text] [Related]
8. Antiepileptic Drug-Activated Constitutive Androstane Receptor Inhibits Peroxisome Proliferator-Activated Receptor
Shizu R; Otsuka Y; Ezaki K; Ishii C; Arakawa S; Amaike Y; Abe T; Hosaka T; Sasaki T; Kanno Y; Miyata M; Yamazoe Y; Yoshinari K
Mol Pharmacol; 2020 Nov; 98(5):634-647. PubMed ID: 32892155
[TBL] [Abstract][Full Text] [Related]
9. Cross-talk between peroxisome proliferator-activated receptor (PPAR) alpha and liver X receptor (LXR) in nutritional regulation of fatty acid metabolism. II. LXRs suppress lipid degradation gene promoters through inhibition of PPAR signaling.
Ide T; Shimano H; Yoshikawa T; Yahagi N; Amemiya-Kudo M; Matsuzaka T; Nakakuki M; Yatoh S; Iizuka Y; Tomita S; Ohashi K; Takahashi A; Sone H; Gotoda T; Osuga J; Ishibashi S; Yamada N
Mol Endocrinol; 2003 Jul; 17(7):1255-67. PubMed ID: 12730332
[TBL] [Abstract][Full Text] [Related]
10. PKCalpha mediated induction of miR-101 in human hepatoma HepG2 cells.
Chiang CW; Huang Y; Leong KW; Chen LC; Chen HC; Chen SJ; Chou CK
J Biomed Sci; 2010 May; 17(1):35. PubMed ID: 20444294
[TBL] [Abstract][Full Text] [Related]
11. MiR-107 suppresses proliferation of hepatoma cells through targeting HMGA2 mRNA 3'UTR.
Wang Y; Chen F; Zhao M; Yang Z; Zhang S; Ye L; Gao H; Zhang X
Biochem Biophys Res Commun; 2016 Nov; 480(3):455-460. PubMed ID: 27773820
[TBL] [Abstract][Full Text] [Related]
12. Regulation of chicken vanin1 gene expression by peroxisome proliferators activated receptor α and miRNA-181a-5p.
Wang Z; Yu J; Hua N; Li J; Xu L; Yao W; Gu Z
Anim Biosci; 2021 Feb; 34(2):172-184. PubMed ID: 32299163
[TBL] [Abstract][Full Text] [Related]
13. Upregulated microRNA-29a by hepatitis B virus X protein enhances hepatoma cell migration by targeting PTEN in cell culture model.
Kong G; Zhang J; Zhang S; Shan C; Ye L; Zhang X
PLoS One; 2011 May; 6(5):e19518. PubMed ID: 21573166
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-122 Inhibits Lipid Droplet Formation and Hepatic Triglyceride Accumulation via Yin Yang 1.
Wu GY; Rui C; Chen JQ; Sho E; Zhan SS; Yuan XW; Ding YT
Cell Physiol Biochem; 2017; 44(4):1651-1664. PubMed ID: 29216638
[TBL] [Abstract][Full Text] [Related]
15. Upregulation of miR-181a impairs lipid metabolism by targeting PPARα expression in nonalcoholic fatty liver disease.
Huang R; Duan X; Liu X; Cao H; Wang Y; Fan J; Wang B
Biochem Biophys Res Commun; 2019 Jan; 508(4):1252-1258. PubMed ID: 30558790
[TBL] [Abstract][Full Text] [Related]
16. Tumour necrosis factor alpha down-regulates the expression of peroxisome proliferator activated receptor alpha (PPARα) in human hepatocarcinoma HepG2 cells by activation of NF-κB pathway.
Lim WS; Ng DL; Kor SB; Wong HK; Tengku-Muhammad TS; Choo QC; Chew CH
Cytokine; 2013 Jan; 61(1):266-74. PubMed ID: 23141142
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-6 inhibition of peroxisome proliferator-activated receptor alpha expression is mediated by JAK2- and PI3K-induced STAT1/3 in HepG2 hepatocyte cells.
Chew GS; Myers S; Shu-Chien AC; Muhammad TS
Mol Cell Biochem; 2014 Mar; 388(1-2):25-37. PubMed ID: 24242046
[TBL] [Abstract][Full Text] [Related]
18. circRNA_0046366 inhibits hepatocellular steatosis by normalization of PPAR signaling.
Guo XY; Sun F; Chen JN; Wang YQ; Pan Q; Fan JG
World J Gastroenterol; 2018 Jan; 24(3):323-337. PubMed ID: 29391755
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-1 inhibits proliferation of hepatocarcinoma cells by targeting endothelin-1.
Li D; Yang P; Li H; Cheng P; Zhang L; Wei D; Su X; Peng J; Gao H; Tan Y; Zhao Z; Li Y; Qi Z; Rui Y; Zhang T
Life Sci; 2012 Oct; 91(11-12):440-447. PubMed ID: 22963810
[TBL] [Abstract][Full Text] [Related]
20. MiR-141 Activates Nrf2-Dependent Antioxidant Pathway via Down-Regulating the Expression of Keap1 Conferring the Resistance of Hepatocellular Carcinoma Cells to 5-Fluorouracil.
Shi L; Wu L; Chen Z; Yang J; Chen X; Yu F; Zheng F; Lin X
Cell Physiol Biochem; 2015; 35(6):2333-48. PubMed ID: 25896253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
